Detalles de la búsqueda
1.
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve (AMBER) and virologically suppressed (EMERALD) participants with neurological and/or psychiatric comorbidities: Week 96 subgroup analysis.
HIV Med
; 24(3): 279-289, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36912173
2.
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study.
Clin Infect Dis
; 71(12): 3110-3117, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879782
3.
Low Incidence and Brief Duration of Gastrointestinal Adverse Events with Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Over 96 Weeks: Post hoc Analyses of AMBER and EMERALD.
J Int Assoc Provid AIDS Care
; 21: 23259582221088202, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35466761
4.
Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study.
J Health Econ Outcomes Res
; 8(1): 88-98, 2021 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34179212
5.
Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis.
HIV Res Clin Pract
; 22(2): 55-61, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33999786
6.
Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus.
J Manag Care Spec Pharm
; 26(2): 117-128, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747357
7.
Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage.
J Manag Care Spec Pharm
; 26(2): 129-141, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747358
8.
Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
AIDS Res Hum Retroviruses
; 35(8): 698-709, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31169022
9.
Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV.
J Manag Care Spec Pharm
; 24(10): 1040-1051, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29877140
Resultados
1 -
9
de 9
1
Próxima >
>>